Let’s start off with what is in the pipeline.
Read More »Starting Insulin Earlier Can Limit Weight Gain for Type 2 Diabetes
Early initiation of therapy hoped to reduce long-term morbidity, mortality by getting to goal earlier; potentially alter the natural history of the disease.
Read More »Once Again, Periodontitis Tied to Diabetes Complications
Adults with type 2 diabetes and microvascular complications have an increased risk for severe periodontitis compared with those without microvascular complications.
Read More »The Disease That May Be a Leading Cause of Death
Survey estimates that diabetes accounts for many more deaths in the United States than are being reported on death certificates — and that diabetes is actually the third leading cause of death.
Read More »Ertugliflozin Monotherapy in Patients with Type 2 Inadequately Controlled
Phase-3 study to evaluate efficacy and safety of ertugliflozin monotherapy.
Read More »A New Combination Diabetes Treatment Could Become the Standard Instead of Insulin
Study shows significant improvement in diabetes control with a 1 point drop in A1c with less hypoglycemia.
Read More »Metformin Reduces Mortality in CKD, CHF, and CLD
FDA label update will increase drug use in persons with historical contraindications or precautions.
Read More »Fenofibrate with a Statin in Type 2 Patients Reduces Long-Term Cardiovascular Risk
Using fibrates to treat hypertriglyceridemia has not shown significant benefit in cardiovascular mortality in previous studies.
Read More »Predicting Diabetes Risk for Children & Adolescents
U.S. researchers confirm that prediabetes risk, presence can be identified using A1C test with same accuracy as other, less convenient tests.
Read More »Screen and Treat to Prevent Type 2
Object of meta-analysis to assess diagnostic accuracy of screening tests for prediabetes and efficacy of interventions (lifestyle or metformin) in preventing diabetes.
Read More »